Metsera (MTSR): Nilai Akuntansi Perusahaan

Logo perusahaan publik Metsera (MTSR)

The development of anti-obesity treatments is currently an extremely competitive and overheated niche where startups must contend with two global behemoths. To survive, Metsera Inc (MTSR) is actively recruiting leading biochemists, securing their loyalty through stock option programs. The market price action, which currently stands at 0.34, underscores the interest in developing new peptides and the company's high probability of being acquired by a major player.

MTSR Kapitalisasi Buku Metsera Therapeutics (01.02.2025 - 29.11.2025)

Rincian metrik lan analitis perusahaan Metsera (MTSR)

- rega lan prakiraan konsensus rega:
Bagan bursa Metsera Therapeutics|MTSR - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Metsera, Inc.|MTSR - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku Saham Metsera|MTSR - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku metsera.com|MTSR - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Metsera Inc|MTSR - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Metsera, Inc.|MTSR - Utang perusahaan|Utang marang nilai buku Metsera, Inc.
Pambiji fundamental:MTSR - Metsera Therapeutics
Barang unggulan Metsera, Inc.

For the startup Metsera Inc (MTSR), which focuses on developing obesity drugs with minimal ESG expenditures, this indicator serves as a measure of the real value of net assets. By analyzing the dynamics of total balance sheet capital, an investor can see the difference between total liabilities and assets in real-time, allowing for an objective assessment of the business's intrinsic value and preventing overpayment for the company.

Analisis pesaing Metsera Inc

ASND: Pambiji Buku Bisnis|Nilai Buku Perusahaan Madrigal Pharmaceuticals MDGL|CORT (corcept.com) - Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan Rhythm Pharmaceuticals, Inc. RYTM|Nilai Aset Bersih Akero Therapeutics, Inc.|MoonLake Pharma (MLTX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Crinetics Corp (CRNX)|Kapitalisasi Buku NAMS (NewAmsterdam Pharma)|soleno.life - Kapitalisasi Buku|Nilai Buku Perusahaan Amicus Therapeutics, Inc. (FOLD)|ETNB: Nilai Akuntansi Perusahaan|AGIO (Agios Pharmaceuticals Inc) - Nilai Buku Perusahaan|Structure Corp (GPCR) - Aset Bersih Perusahaan|MDXG (MiMedx Group, Inc.) - Kapitalisasi Buku|Kapitalisasi Buku rezolutebio.com (RZLT)|Lexicon Pharmaceuticals, Inc. (LXRX) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan MBX (MBX Biosciences, Inc.)|Altimmune Corp - Nilai Buku Perusahaan|Aset Bersih Perusahaan Aardvark Pharma AARD|SGMT (Sagimet Biosciences) - Kapitalisasi Buku|bioagelabs.com (BIOA) - Ekuitas Perusahaan|BMEA - Aset Bersih Perusahaan|Quince Therapeutics, Inc. (QNCX) - Total Aset Bersih|GUTS (Fractyl) - Kapitalisasi Buku|Kapitalisasi Buku vTv Therapeutics Inc|Kapitalisasi Buku Agape ATP Corporation (ATPC)|Nilai Buku Perusahaan PLUR (pluri-biotech.com)|SYBX: Nilai Buku Perusahaan|Lipocine Inc - Ekuitas Perusahaan|MTNB - Nilai Buku Perusahaan|SPRB - Nilai Buku Perusahaan|Galecto, Inc. - Kapitalisasi Buku|CTCX (carmellrx.com) - Pambiji Buku Bisnis|LUMO: Nilai Buku Perusahaan|Pambiji Buku Bisnis ONVO|Nilai Buku Perusahaan RDUS (Radius Health)